Edwards Lifesciences Corporation Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment
Edwards Lifesciences Corporation (EW) reported Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment of -$400.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Income Statement › Other Income
us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1 · last filed 2026-02-25
- Edwards Lifesciences Corporation defined benefit plan, net periodic benefit cost (credit), gain (loss) due to settlement and curtailment for fiscal 2025 was -$400.00K.
- Edwards Lifesciences Corporation defined benefit plan, net periodic benefit cost (credit), gain (loss) due to settlement and curtailment for fiscal 2024 was -$1.20M.
- Edwards Lifesciences Corporation defined benefit plan, net periodic benefit cost (credit), gain (loss) due to settlement and curtailment for fiscal 2023 was $0.00.
- Edwards Lifesciences Corporation defined benefit plan, net periodic benefit cost (credit), gain (loss) due to settlement and curtailment for fiscal 2022 was -$100.00K.
| Period end | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment 12 month |
|---|---|
| 2025-12-31 | -$400.00K 10-K · filed 2026-02-25 |
| 2024-12-31 | -$1.20M 10-K · filed 2026-02-25 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-25 |
| 2022-12-31 | -$100.00K 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |